phosphorus-radioisotopes and Peritoneal-Diseases

phosphorus-radioisotopes has been researched along with Peritoneal-Diseases* in 2 studies

Other Studies

2 other study(ies) available for phosphorus-radioisotopes and Peritoneal-Diseases

Article	Year
Intracavitary chromic phosphate (32P) colloidal suspension therapy. Cancer, 1981, Dec-15, Volume: 48, Issue:12 Two-hundred-eighty-nine patients received treatment with chronic phosphate (32P) colloidal suspension (CPCS) 346 times since 1963. One-hundred-seventy-eight patients received 200 intraperitoneal treatments. One-hundred-fifteen patients received 144 intrapleural treatments. Six patients received both intraperitoneal and intrapleural treatments. Two patients received two intrapericardial treatments. Results of therapy were evaluated three months later and then at yearly intervals. In those patients who survived three months, the referring physician observed improvement in 85% of intraperitoneal treatment and in 75% of intrapleural treatments. Topics: Brachytherapy; Chromium; Chromium Compounds; Follow-Up Studies; Humans; Male; Neoplasms; Peritoneal Diseases; Peritoneum; Phosphates; Phosphorus Radioisotopes; Pleura; Pleural Effusion	1981
[Long-time results of intracavitary isotope therapy of malignant effusions]. Nuclear-Medizin, 1974, Nov-30, Volume: 13, Issue:3 Topics: Ascitic Fluid; Chromates; Female; Follow-Up Studies; Gold Colloid, Radioactive; Humans; Neoplasms; Palliative Care; Peritoneal Cavity; Peritoneal Diseases; Phosphorus Radioisotopes; Pleural Effusion; Punctures; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Silicic Acid; Time Factors; Yttrium Isotopes	1974

Article

Year

Intracavitary chromic phosphate (32P) colloidal suspension therapy.

Cancer, 1981, Dec-15, Volume: 48, Issue:12

Two-hundred-eighty-nine patients received treatment with chronic phosphate (32P) colloidal suspension (CPCS) 346 times since 1963. One-hundred-seventy-eight patients received 200 intraperitoneal treatments. One-hundred-fifteen patients received 144 intrapleural treatments. Six patients received both intraperitoneal and intrapleural treatments. Two patients received two intrapericardial treatments. Results of therapy were evaluated three months later and then at yearly intervals. In those patients who survived three months, the referring physician observed improvement in 85% of intraperitoneal treatment and in 75% of intrapleural treatments.

Topics: Brachytherapy; Chromium; Chromium Compounds; Follow-Up Studies; Humans; Male; Neoplasms; Peritoneal Diseases; Peritoneum; Phosphates; Phosphorus Radioisotopes; Pleura; Pleural Effusion

1981

[Long-time results of intracavitary isotope therapy of malignant effusions].

Nuclear-Medizin, 1974, Nov-30, Volume: 13, Issue:3

Topics: Ascitic Fluid; Chromates; Female; Follow-Up Studies; Gold Colloid, Radioactive; Humans; Neoplasms; Palliative Care; Peritoneal Cavity; Peritoneal Diseases; Phosphorus Radioisotopes; Pleural Effusion; Punctures; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Silicic Acid; Time Factors; Yttrium Isotopes

1974